Long lasting glucagon-like peptide 2 (glp-2) for the...

Details Long lasting glucagon-like peptide 2 (glp-2) for the... Long lasting glucagon-like peptide 2 (glp-2) for the...

2006-09-26

2006-09-26

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07112567

ABSTRACT:
This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.

REFERENCES:
patent: 4462941 (1984-07-01), Lee et al.
patent: 5493007 (1996-02-01), Burnier et al.
patent: 5580853 (1996-12-01), Sytkowski
patent: 5612034 (1997-03-01), Pouletty et al.
patent: 5654276 (1997-08-01), Barrett et al.
patent: 5789379 (1998-08-01), Drucker et al.
patent: 5834428 (1998-11-01), Drucker
patent: 5843440 (1998-12-01), Pouletty et al.
patent: 5952301 (1999-09-01), Drucker
patent: 5990077 (1999-11-01), Drucker
patent: 5994500 (1999-11-01), Drucker et al.
patent: 6051557 (2000-04-01), Drucker
patent: 6103233 (2000-08-01), Pouletty et al.
patent: 6184201 (2001-02-01), Summer-Smtih et al.
patent: 4122210 (1993-01-01), None
patent: 0602290 (1994-04-01), None
patent: 93/25217 (1993-12-01), None
patent: 95/10302 (1995-04-01), None
patent: 96/06626 (1996-03-01), None
patent: 98/08872 (1998-03-01), None
patent: WO 98/24813 (1998-06-01), None
patent: 99/24075 (1999-05-01), None
patent: 99/24462 (1999-05-01), None
patent: 99/48536 (1999-09-01), None
patent: 00/69900 (2000-11-01), None
patent: 00/69911 (2000-11-01), None
patent: 00/76550 (2000-12-01), None
patent: 00/76551 (2000-12-01), None
patent: 01/68142 (2001-09-01), None
Proceedings of the 8thAmerican Peptide Symposium, 1983, 409-412.
Biotech Report, 1994/1995, 106-107.
Proc. Natl. Acad. Sci., 1996, 93, (115), 7911-7916.
Int. J. Biochem. Cell. Biol., 1998, 30, 1281-1284.
Endocrinology, 1982, 110(3), 1049-1051.
Chem Pharm. Bull. 27(8) 1942-1944 (1979).
American Journal of Physiology, Endocrinology and Metabolism, 2000, 278(1), E134-E139.
Nature Biotechnology, Nature Publishing, 1997, 15(7), 673-677.
Regulatory Peptides, 2000, 90(1-3), 27-32.
Trends in Endocrinology and Metabolism, 2000, 11(10), 401-405.
Endocrinology, 2001, 142(2), 521-527.
J. Dev. Physiol., 1989, 12, 55-62.
Anti-Cancer DRugs, 1997, 8, 677-685.
Biopolymers (Peptide Science), 1998, 47, 451-463.
Ann Rev Neuros. 1989 7 228-295.
J. Biol. Chem. 1995 270/431.
Proc. Natl. Acad. Sci., 1986, 83, 265-269.
TINS, 1993, 16, 403-409.
Biochemistry, 2000, 39, 8888-8894.
Proceedings of the 8thAmerican Peptide Symposium, 1983, 409-412.
Biotech Report, 1994/1995, 106-107.

Affiliated with

Also associated with

Rating

Long lasting glucagon-like peptide 2 (glp-2) for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long lasting glucagon-like peptide 2 (glp-2) for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long lasting glucagon-like peptide 2 (glp-2) for the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3532293